Rodefitzsimmons4071

Blood sugar levels returned to a nondiabetic range upon discontinuation of alpelisib, and she is currently off all antihyperglycemic agents.

Although PI3KCA inhibitors remain a promising drug in patients with metastatic breast cancer who have not responded to previous treatment, patients must be closely monitored for adverse effects such as hyperglycemia. Hyperglycemia could be a potentially limiting side effect of alpelisib. The optimal management of hyperglycemia induced by alpelisib warrants further research.

Although PI3KCA inhibitors remain a promising drug in patients with metastatic breast cancer who have not responded to previous treatment, patients must be closely monitored for adverse effects such as hyperglycemia. Hyperglycemia could be a potentially limiting side effect of alpelisib. The optimal management of hyperglycemia induced by alpelisib warrants further research.

Hyponatremia associated with cerebrospinal fluid (CSF) drainage is primarily limited to pediatric patients. Only 1 case in an adult, after pituitary surgery, has been described. We present the first adult case, to our knowledge, of lumbar CSF drainage associated with the syndrome of inappropriate antidiuretic hormone (SIADH) in a patient with a traumatic basilar skull fracture.

Serum and urine samples were evaluated for hyponatremia. Computed tomography and magnetic resonance imaging were performed to evaluate the fractures.

A 31-year-old woman was hospitalized with traumatic facial and skull base fractures and managed conservatively. Four days into her hospital stay, she underwent lumbar CSF drainage for 6 days to treat a CSF leak. On examination, the patient remained hemodynamically stable and euvolemic. Sodium levels decreased from 142 to 136 mmol/L (normal, 135-146 mmol/L) on the day before and after lumbar drain placement, respectively, down to a nadir of 124 mmol/L over 3 subsequent days. ABT-199 Serumosmolality was 260 mOsm/kg (275-295 mOsm/kg); urine osmolality, 482 mOsm/kg; urine Na, 175mmol/L; and thyroid-stimulating hormone, 4.0 μIU/mL (0.3-4.7 μIU/mL). The patient received treatment with sodium tablets, fluid restriction, and hypertonic saline for a diagnosis of SIADH. Sodium levels normalized from 131 to 136 mmol/L within 16 hours after lumbar drain removal.

This case illustrated a temporal association of SIADH with CSF drainage in an adult. Although this could be coincidental because a basilar skull fracture can lead to SIADH, it raises the possibility that CSF lumbar drainage contributed to the patient's SIADH.

This case illustrated a temporal association of SIADH with CSF drainage in an adult. Although this could be coincidental because a basilar skull fracture can lead to SIADH, it raises the possibility that CSF lumbar drainage contributed to the patient's SIADH.

Tyrosine-kinase inhibitors (TKIs) are chemotherapeutic agents associated with increased thyroid-hormone requirements and altered deiodinase activity. We present the first case to link these findings to the TKI ibrutinib.

Serial thyroid-stimulating hormone (TSH), free-thyroxine (FT4), free-triiodothyronine (FT3), and reverse-triiodothyronine (rT3) levels were assessed.

An 80-year-old, 62-kg woman with hypothyroidism secondary to total thyroidectomy for stage I papillary thyroid cancer, on maintenance levothyroxine (LT4) 137 μg daily, presented for follow-up. Compared to one year prior, the patient's weight had increased by 2 kg and TSH from 2.58 to 27.60 μIU/mL (normal 0.45-4.50 μIU/mL) while on pantoprazole. Ibrutinib, her other medication, had been started seven months prior for chronic lymphocytic leukemia. Despite sequential confirmation of properLT4adherence and self-administration, adjustment ofLT4to 150 μg, and discontinuation of pantoprazole, the patient's hypothyroid symptoms worsened, and the TSH was 73.90 μIU/mL six months later.LT4was increased to 175 μg six days a week and 262.5 μg once weekly. Two months later, the TSH was 3.92 μIU/mL (steady-state condition), FT4 2.32 ng/dL (normal 0.82-1.77 ng/dL), FT3 1.6 pg/mL (normal 2.0-4.4 pg/mL), and rT3 69.6 ng/dL (normal 9.2-24.1 ng/dL). Ibrutinib was discontinued the next month due to gastrointestinal side effects and elevated blood pressure. Four months later,LT4had been reduced to 150 μg, and the FT4 reached 1.92 ng/dL, FT3 2.0 pg/mL, and rT3 26.6 ng/dL.

This report links ibrutinib to increased thyroid-hormone requirements in a thyroidectomized woman whose decreased T3T4, T3rT3, and T4rT3 ratios suggested type 3 deiodinase induction and type 2 deiodinase inhibition.

This report links ibrutinib to increased thyroid-hormone requirements in a thyroidectomized woman whose decreased T3T4, T3rT3, and T4rT3 ratios suggested type 3 deiodinase induction and type 2 deiodinase inhibition.

We report a case of pituitary apoplexy (PA) with negative radiographic findings for PA and cerebrospinal fluid (CSF) analysis consistent with neutrophilic meningitis. PA is a rare endocrinopathy requiring prompt diagnosis and treatment. Presentation with acute neutrophilic meningitis is uncommon.

The diagnostic modalities included pituitary function tests (adrenocorticotropic hormone, thyroid-stimulating hormone, luteinizing hormone, prolactin), brain computed tomography and magnetic resonance imaging (MRI), and CSF analysis.

A 67-year-old man presented with worsening headache, nausea, and retching. He was somnolent with an overall normal neurologic examination other than a peripheral vision defect in the left eye. MRI showed a pituitary mass bulging into the suprasellar cistern with optic chiasm elevation, consistent with pituitary macroadenoma. Laboratory evaluation revealed decreased levels of adrenocorticotropic hormone, random cortisol, thyroid-stimulating hormone, thyroxine, luteinizing hormone, a While neuroimaging can help detect PA, the diagnosis of PA remains largely clinical.

Renal papillary necrosis (RPN) occurring in primary hyperparathyroidism (PHPT) has not been reported. We present a 50-year-old woman who manifested RPN associated with hypercalciuria and normocalcemic PHPT.

The diagnosis of RPN was based on imaging studies (ultrasound and computed tomography [CT] scan). PHPT was diagnosed with high parathyroid hormone (PTH) and high/normal serum calcium.

A 38-year-old woman was evaluated for hypercalcemia (serum calcium, 11.8 mg/dL; ionized calcium, 6.3 mg/dL; phosphorus, 1.8 mg/dL; intact PTH, 98 pg/mL; and 24-hour urine calcium, 543 mg). Renal ultrasound showed no nephrocalcinosis or nephrolithiasis. A parathyroid scan revealed a left parathyroid adenoma. The patient underwent parathyroidectomy, and she became normocalcemic with normal serum PTH levels postoperatively. One year later, she was diagnosed with a left-sided bronchial carcinoid tumor. Following surgery, a surveillance gallium

positron emission tomography/CT scan performed 2 years later was negative for metastases.